Cargando…

Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?

Detalles Bibliográficos
Autor principal:	Wang, Andrew Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457346/ https://www.ncbi.nlm.nih.gov/pubmed/26137516 http://dx.doi.org/10.1016/j.ebiom.2014.11.013

Ejemplares similares

Rolling Circle Transcription of Tandem siRNA to Generate Spherulitic RNA Nanoparticles for Cell Entry
por: Guo, Peixuan
Publicado: (2012)

siRNA targeting ANGPTL3 stands in the spotlight for lipid-lowering therapy
por: Hu, Bo, et al.
Publicado: (2023)

siRNA goes after diseases of the bone
por: Coles, Andrew H.
Publicado: (2023)

Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
por: Ben-David-Naim, Meital, et al.
Publicado: (2019)

siRNA Conjugated Nanoparticles—A Next Generation Strategy to Treat Lung Cancer
por: Itani, Rasha, et al.
Publicado: (2019)

Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice
por: Bogorad, Roman L, et al.
Publicado: (2014)

Bridging siRNA strands for better function
por: Rossi, John J.
Publicado: (2023)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Toward learning the rules that predict siRNA efficacy
por: Bofill-De Ros, Xavier
Publicado: (2023)

Harnessing the potential of lipid nanoparticles for the delivery of chemically modified siRNA to combat hepatic adenovirus infection
por: Shubhra, Quazi T.H., et al.
Publicado: (2023)

Lipid nanoparticle siRNA cocktails for the treatment of mantle cell lymphoma
por: Knapp, Christopher M., et al.
Publicado: (2018)

Formulation Strategies, Characterization, and In Vitro Evaluation of Lecithin-Based Nanoparticles for siRNA Delivery
por: Pérez, Sebastián Ezequiel, et al.
Publicado: (2012)

Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
por: Chakraborty, Chiranjib, et al.
Publicado: (2017)

Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013)

siRNA for Influenza Therapy
por: Barik, Sailen
Publicado: (2010)

Nanoparticle Formulation to Improve the Efficacy of Radiation Therapy Against Radiation-resistant Leukemia
por: Zhao, Jun, et al.
Publicado: (2015)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex
por: Wang, Xiang, et al.
Publicado: (2019)

Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles
por: Kummitha, China M, et al.
Publicado: (2012)

Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013)

Generation of siRNA Nanosheets for Efficient RNA Interference
por: Kim, Hyejin, et al.
Publicado: (2016)

BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, and In Vitro siRNA Delivery
por: Yogasundaram, Haran, et al.
Publicado: (2012)

Recent Developments in Nanoparticle-Based siRNA Delivery for Cancer Therapy
por: Lee, Jong-Min, et al.
Publicado: (2013)

Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
por: Butowska, Kamila, et al.
Publicado: (2023)

Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model
por: Linder, Benedikt, et al.
Publicado: (2019)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]
Publicado: (2019)

Folate-targeted selenium nanoparticles deliver therapeutic siRNA to improve hepatocellular carcinoma therapy
por: Xia, Yu, et al.
Publicado: (2018)

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19
por: Idris, Adi, et al.
Publicado: (2021)

Rational polyelectrolyte nanoparticles endow preosteoclast-targeted siRNA transfection for anabolic therapy of osteoporosis
por: Zhang, Zheng, et al.
Publicado: (2023)

Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer
por: Dinis Ano Bom, Ana Paula, et al.
Publicado: (2019)

Evaluating side effects of nanoparticle‐mediated siRNA delivery to mesenchymal stem cells using next generation sequencing and enrichment analysis
por: Malcolm, Dominic W., et al.
Publicado: (2016)

siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication
por: Kok, Kin-Hang, et al.
Publicado: (2009)

RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model
por: Lee, Tae Jin, et al.
Publicado: (2015)

Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles
por: Castillo, Betzaida, et al.
Publicado: (2012)

ECO/siRNA nanoparticles and breast cancer metastasis
por: Lu, Zheng-Rong, et al.
Publicado: (2015)

Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside
por: Zatsepin, Timofei S, et al.
Publicado: (2016)

Regulating Oncogenic LncRNA DANCR with Targeted ECO/siRNA Nanoparticles for Non-Small Cell Lung Cancer Therapy
por: Nicolescu, Calin, et al.
Publicado: (2022)

Development of a Combined Lipid-Based Nanoparticle Formulation for Enhanced siRNA Delivery to Vascular Endothelial Cells
por: He, Yutong, et al.
Publicado: (2022)

Ocular neuroprotection by siRNA targeting caspase-2
por: Ahmed, Z, et al.
Publicado: (2011)

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia, Yu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tm1jaus98i65jc81kh0spaaiuc